A genome-wide CRISPR screen identifies host factors that regulate SARS-CoV-2 entry

Nat Commun. 2021 Feb 11;12(1):961. doi: 10.1038/s41467-021-21213-4.

Abstract

The global spread of SARS-CoV-2 is posing major public health challenges. One feature of SARS-CoV-2 spike protein is the insertion of multi-basic residues at the S1/S2 subunit cleavage site. Here, we find that the virus with intact spike (Sfull) preferentially enters cells via fusion at the plasma membrane, whereas a clone (Sdel) with deletion disrupting the multi-basic S1/S2 site utilizes an endosomal entry pathway. Using Sdel as model, we perform a genome-wide CRISPR screen and identify several endosomal entry-specific regulators. Experimental validation of hits from the CRISPR screen shows that host factors regulating the surface expression of angiotensin-converting enzyme 2 (ACE2) affect entry of Sfull virus. Animal-to-animal transmission with the Sdel virus is reduced compared to Sfull in the hamster model. These findings highlight the critical role of the S1/S2 boundary of SARS-CoV-2 spike protein in modulating virus entry and transmission and provide insights into entry of coronaviruses.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • A549 Cells
  • Angiotensin-Converting Enzyme 2 / genetics
  • Angiotensin-Converting Enzyme 2 / metabolism
  • Animals
  • COVID-19 / genetics
  • COVID-19 / virology*
  • CRISPR-Cas Systems*
  • Chlorocebus aethiops
  • Disease Models, Animal
  • Endosomes / virology
  • Genome-Wide Association Study*
  • HeLa Cells
  • Host-Pathogen Interactions*
  • Humans
  • Mesocricetus
  • SARS-CoV-2 / physiology*
  • Serine Endopeptidases
  • Spike Glycoprotein, Coronavirus / metabolism
  • Vero Cells
  • Virus Internalization*

Substances

  • Spike Glycoprotein, Coronavirus
  • spike protein, SARS-CoV-2
  • ACE2 protein, human
  • Angiotensin-Converting Enzyme 2
  • Serine Endopeptidases